Strides Shasun has received the final approval from the US Food and Drug Administration for cetirizine hydrochloride capsules that are used in relieving allergy symptoms.

Strides Shasun has said in a BSE filing that “It has received approval from the US FDA for certizine hydrochloride capsules, 10 mg (liquid filled capsules OTC).”

According to the company the said product is going to be manufactured at its facility in Bengaluru and is ready for launch.

Read EquityPandit’s Technical Analysis on Nifty Pharma